OVERVIEW

The Scott M. Hammer Annual Update on HIV Management is organized by International Antiviral Society-USA (IAS-USA) and will be held on Mar 16, 2026 at NYU Skirball Center, New York, United States of America.

Program Description:
Join us in New York City for one of the most anticipated IAS–USA annual courses, where science, clinical expertise, and advances in HIV care come together. This dynamic, in-person event at the NYU Skirball Center will convene leading experts and frontline clinicians for an exciting day of learning, discussion, and practical clinical insights. This course is also offered virtually for those unable to attend in person.

Stay on the cutting edge of HIV medicine with timely updates and lively case-based discussions. Highlights include key takeaways from Conference for Retroviruses and Opportunistic Infections (CROI) 2026, an in-depth look at the state of long-acting therapeutics and their use in diverse populations, and a comprehensive session on HIV and pregnancy covering vaccines, treatment and prevention strategies, and breastfeeding guidelines. Engage in interactive antiretroviral therapy case discussions, and explore prevention strategies, vaccine guidelines, management of substance use disorders, and diabetes care in people with and at risk for HIV.

Assessment of Needs:
Rapid advances in HIV disease management require the ongoing attention of clinicians involved in direct patient care. This course will address the implications of new information on strategies for the clinical management of HIV and related comorbidities. Information will be presented through a mix of didactic lectures, clinically relevant cases, and expert panel discussions developed and led by an expert faculty of HIV/AIDS clinicians and researchers.

Learning Objectives:
After participating in the activity, learners will be able to:

Implement the latest recommendations for initiating and changing antiretroviral therapy in particular clinical circumstances, such as comorbid conditions, coinfections, pregnancy, and issues in older patients
Describe the most current data from recent HIV scientific conferences, including research on new and investigational antiretroviral drugs
Review treatment and prevention strategies for HIV and pregnancy, including vaccine and breastfeeding guidance
Optimize HIV prevention and management in diverse patient populations
Discuss current vaccine guidelines for people with HIV, including safety, efficacy, and special considerations for children and pregnant women
Apply evidence-based recommendations for the prevention and management of substance use disorders and comorbidities in people with HIV
Summarize important considerations for managing persons with HIV and diabetes

Preliminary Topics:

Difficult cases in antiretroviral therapy
Key updates from CROI 2026
Long-acting therapeutics: what’s new, who benefits, and how to manage treatment failure
HIV and pregnancy: vaccines, treatment and prevention strategies, and breastfeeding guidelines
HIV prevention innovations and implementation strategies
Vaccine guidelines for people with HIV, including safety and efficacy in special populations
Substance use disorders: medications for opioid use disorder (MOUD), emerging therapies, and management of comorbidities
Diagnosis, treatment, and complications of diabetes in people with HIV